K Sampi

Jikei University School of Medicine — Japan

Medicine · Health Sciences

12h-index534citations101works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(28), Lymphoma Diagnosis and Treatment(27), Acute Myeloid Leukemia Research(23), Chronic Lymphocytic Leukemia Research(21), Neutropenia and Cancer Infections(14)

Publications101 total

A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
PubMed·1999· 4 cited
A phase II study employing combination regimens containing KRN8602 in drug-resistant acute myeloid leukemia and acute lymphoblastic leukemia
Anti-Cancer Drugs·1999· 1 cited
[Pilot late phase II study of KRN8602 (MX2), a novel anthracycline derivative, for acute leukemia--a dose finding study in combination].
PubMed·1999· 1 cited
[Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
PubMed·1998
[Immunoblastic lymphadenopathy-like T cell lymphoma with high levels of serum interleukin-6, cold agglutinin disease, and immune thrombocytopenia].
PubMed·1998· 6 cited
[Phase II study of KRN8602 (MX2) for malignant lymphoma].
PubMed·1998
[Empiric therapy with fluconazole in granulocytopenic patients with carcinoma or leukemia].
PubMed·1994· 8 cited
[Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
PubMed·1993
Differentiation of human myeloblastic leukemia ML-1 cells into macrophages by staurosporine, an inhibitor of protein kinase activities.
PubMed·1993· 4 cited
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
PubMed·1993· 14 cited
Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cells.
PubMed·1992· 17 cited
[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study].
PubMed·1992· 1 cited
[Malignant lymphoma occurring subsequent to autoimmune disease].
PubMed·1992· 4 cited
[A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
PubMed·1992· 10 cited
Stage I malignant lymphoma of Waldeyer's ring: Frequent relapse after radiation therapy
Annals of Oncology·1992· 11 citedOpen Access
[Intensive carboquone and cryopreserved autologous bone marrow transplantation for relapsed malignancies].
PubMed·1992
78. Effects of inhibitors of protein kinase activities on differentiation of human myeloid leukemia cells
Biomedicine & Pharmacotherapy·1992
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase
FEBS Letters·1991· 28 cited
Induction of differentiation of human myeloid leukemia HL-60 cells by novel pyrimidine nucleoside analogs
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research·1991· 19 cited
[An 8; 21 chromosome translocation associated leukemia presenting with large intestinal granulocytic sarcoma: a report of two cases].
PubMed·1991· 8 cited
page 1 of 6Next →

Frequent Co-authors

Yoshio Honma(10), Motoo Hozumi(9), Masaharu Sakurai(8), Nobuo Maseki(6), T Masaoka(6), Yasuhiko Kaneko(5), Makoto Makishima(5), Masao Hattori(5), Masashi Hattori(5), R Kumai(4), I Kimura(4), Kazuo Motoyoshi(3), S Shirakawa(3), T Ohnoshi(3), Y Takemoto(3), Yasushi Kuraishi(3), K Tamura(3), Masatoshi Sakurai(3), Masaya Hattori(3), Yūkō Fujita(2)